No Data
No Data
Vera Therapeutics Initiated With an Outperform at Scotiabank
Vera Therapeutics (NASDAQ:VERA) Has Debt But No Earnings; Should You Worry?
TD Cowen Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $60
Vera Therapeutics (VERA) Gets a Buy From TD Cowen
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jefferies Initiates Vera Therapeutics(VERA.US) With Buy Rating, Announces Target Price $53